JMS approves JPY500m commitment

The medical device manufacturer has backed a Japan-focused venture capital fund.

Institution: JMS
Headquarters: Hiroshima, Japan
AUM: JPY64.56bn
Bitesize: $1-5m

JMS has approved a JPY500 million ($4.6 million; €4.17 million) commitment to MPI-2 Investment Limited Partnership, a Japan-focused venture capital fund investing in the healthcare sector.

As illustrated below, it is the firm’s first private equity commitment.

Platinum subscribers may click here for the investor’s full profile, including key contacts, allocation strategy and fund investments.